TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

J&J wins U.S. approval for TB tablet

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

JNJ $70.10 +$0.62

at close on MONDAY

Daily Photo Galleries

Business Photo Galleries

By Anna Edney C.2012 Bloomberg News
Monday, Dec. 31, 2012, 10:30 p.m.
 

Johnson & Johnson won regulatory approval for its tuberculosis tablet Sirturo, the first drug in 40 years that provides a new way to treat the contagious lung infection.

The Food and Drug Administration cleared Sirturo to be added to therapies for use by adults whose illness is resistant to multiple medicines, the New Brunswick, N.J.- based company said Monday.

While tuberculosis was once the leading cause of death in the nation, the drug-resistant version of the illness affected about 98 people last year, according to the Centers for Disease Control and Prevention.

Subscribe today! Click here for our subscription offers.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Shift in what powers the grid raises concerns about fuel diversity
  2. Protesters refuse to pay back education loans
  3. Women encouraged to become engineers
  4. Free-market thinker Hall to lead Congressional Budget Office
  5. Unruly photo collection? Get it under control with organizing program
  6. Economist Hubbard says GOP should grow number of workers
  7. ‘Shark Tank’ companies have change of heart
  8. Highmark lays off nearly 100 workers, mostly in IT, as membership declines
  9. Tech sector’s stocks strong
  10. Top residential, commercial deals of the week — March 1
  11. Severance tax on natural gas drilling backed by Pa. voters